Legacy Mallinckrodt Second Quarter 2025 Results Delivers Second Quarter Net Sales of $485.1 Million, Reflecting a 5.7% Year-Over-Year Decrease on a Reported Basis; Excluding Impact of Therakos® Divestiture, Net Sales Grew 8.5% Reports Net Income of $2.4 Million and Adjusted EBITDA of $137....
Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance
Seeking Alpha / 21 hours ago 1 Views
Comments